Literature DB >> 20958220

Different radiosensitivity of CD4(+)CD25(+) regulatory T cells and effector T cells to low dose gamma irradiation in vitro.

Mengde Cao1, Roniel Cabrera, Yiling Xu, Chen Liu, David Nelson.   

Abstract

PURPOSE: To determine the radiosensitivity difference of human Cluster of Differentiation (CD)4(+)CD25(+) regulatory T cells (Treg) and effector T cells to low dose gamma ray and elucidate the underlying mechanisms in vitro.
MATERIALS AND METHODS: Blood samples were collected from five health subjects and five patients with advanced hepatocellular carcinoma (HCC). Treg and CD4(+)CD25⁻ T cells were selected using magnetic microbeads. The proliferative profiles, cytokine secretion, and differential expressions of apoptosis-related proteins in Treg and CD4(+)CD25⁻ T cells were compared using [³H]-thymidine incorporation, Luminex assay and flow cytometry when treated with various low doses of γ-ray.
RESULTS: A dose-dependent reduction of proliferation in response to irradiation which paralleled the induction of apoptosis existed in Treg and CD4(+)CD25⁻ T cells. Treg were more radiosensitive to low-dose irradiation (0.94 Gray [Gy]) than effector T cells. The interferon-γ (IFNγ) was significantly upregulated and interleukin 10 (IL-10) was significantly downregulated in irradiated Treg. An enhanced immune response to low dose gamma ray existed in the peripheral blood in patients with advanced HCC. Higher levels of active caspase-3, CD95, B cell lymphoma 2 (Bcl-2)-associated X protein (Bax) expression were observed in Treg compared to CD4(+)CD25⁻ T cells. In addition, gamma irradiation activated CD4(+)CD25⁻ T cells to express CD25.
CONCLUSIONS: These studies revealed that Treg were more radiosensitive than CD4(+)CD25⁻ T cells to low dose irradiation. Higher expressions of apoptosis-related proteins such as caspase-3, CD95 and Bax were observed in Treg when compared to CD4(+)CD25⁻ T cells. Our results suggest that treatment with low doses of gamma irradiation may be a viable strategy to enhance immune response in patients with advanced HCC.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20958220      PMCID: PMC3806980          DOI: 10.3109/09553002.2010.518208

Source DB:  PubMed          Journal:  Int J Radiat Biol        ISSN: 0955-3002            Impact factor:   2.694


  49 in total

1.  Capsaicin-induced apoptosis in SK-Hep-1 hepatocarcinoma cells involves Bcl-2 downregulation and caspase-3 activation.

Authors:  M Y Jung; H J Kang; A Moon
Journal:  Cancer Lett       Date:  2001-04-26       Impact factor: 8.679

2.  Bax-induced caspase activation and apoptosis via cytochrome c release from mitochondria is inhibitable by Bcl-xL.

Authors:  D M Finucane; E Bossy-Wetzel; N J Waterhouse; T G Cotter; D R Green
Journal:  J Biol Chem       Date:  1999-01-22       Impact factor: 5.157

3.  Enhancement of antitumor immunity by low-dose total body irradiationis associated with selectively decreasing the proportion and number of T regulatory cells.

Authors:  Rongjun Liu; Shudao Xiong; Lei Zhang; Yiwei Chu
Journal:  Cell Mol Immunol       Date:  2010-02-08       Impact factor: 11.530

Review 4.  The immunobiology of low-dose total-body irradiation: more questions than answers.

Authors:  A Safwat
Journal:  Radiat Res       Date:  2000-05       Impact factor: 2.841

Review 5.  Emerging roles of caspase-3 in apoptosis.

Authors:  A G Porter; R U Jänicke
Journal:  Cell Death Differ       Date:  1999-02       Impact factor: 15.828

6.  Gamma irradiation alters the phenotype and function of CD4+CD25+ regulatory T cells.

Authors:  Mengde Cao; Roniel Cabrera; Yiling Xu; Chen Liu; David Nelson
Journal:  Cell Biol Int       Date:  2009-03-04       Impact factor: 3.612

Review 7.  Radiation therapy and Toll-like receptor signaling: implications for the treatment of cancer.

Authors:  R E Roses; M Xu; G K Koski; B J Czerniecki
Journal:  Oncogene       Date:  2008-01-07       Impact factor: 9.867

8.  Gamma irradiation of human dendritic cells influences proliferation and cytokine profile of T cells in autologous mixed lymphocyte reaction.

Authors:  Meng-De Cao; Zong-De Chen; Ying Xing
Journal:  Cell Biol Int       Date:  2004       Impact factor: 3.612

9.  Role of CD28/B7 costimulation and IL-12/IL-10 interaction in the radiation-induced immune changes.

Authors:  S Z Liu; S Z Jin; X D Liu; Y M Sun
Journal:  BMC Immunol       Date:  2001-08-07       Impact factor: 3.615

10.  Radiation-induced, immunologically mediated regression of an established tumor as an example of successful therapeutic immunomanipulation. Preferential elimination of suppressor T cells allows sustained production of effector T cells.

Authors:  R J North
Journal:  J Exp Med       Date:  1986-11-01       Impact factor: 14.307

View more
  18 in total

1.  Low-dose radiation modulates human mesenchymal stem cell proliferation through regulating CDK and Rb.

Authors:  Lei Yang; Ziling Liu; Chen Chen; Xiaofeng Cong; Zhi Li; Shasha Zhao; Meng Ren
Journal:  Am J Transl Res       Date:  2017-04-15       Impact factor: 4.060

Review 2.  The interplay between cancer associated fibroblasts and immune cells in the context of radiation therapy.

Authors:  Miles Piper; Adam C Mueller; Sana D Karam
Journal:  Mol Carcinog       Date:  2020-05-04       Impact factor: 4.784

3.  Long-Lasting Impact of Neonatal Exposure to Total Body Gamma Radiation on Secondary Lymphoid Organ Structure and Function.

Authors:  Javier Rangel-Moreno; Maria de la Luz Garcia-Hernandez; Rosalio Ramos-Payan; Jamie Biear; Eric Hernady; Mark Y Sangster; Troy D Randall; Carl J Johnston; Jacob N Finkelstein; Jacqueline P Williams
Journal:  Radiat Res       Date:  2015-09-23       Impact factor: 2.841

Review 4.  Immune recognition of irradiated cancer cells.

Authors:  Erik Wennerberg; Claire Vanpouille-Box; Sophia Bornstein; Takahiro Yamazaki; Sandra Demaria; Lorenzo Galluzzi
Journal:  Immunol Rev       Date:  2017-11       Impact factor: 12.988

Review 5.  Combining Heavy-Ion Therapy with Immunotherapy: An Update on Recent Developments.

Authors:  Alexander Helm; Daniel K Ebner; Walter Tinganelli; Palma Simoniello; Alessandra Bisio; Valentina Marchesano; Marco Durante; Shigeru Yamada; Takashi Shimokawa
Journal:  Int J Part Ther       Date:  2018-09-21

Review 6.  Deciphering the Intricate Roles of Radiation Therapy and Complement Activation in Cancer.

Authors:  Jacob Gadwa; Sana D Karam
Journal:  Int J Radiat Oncol Biol Phys       Date:  2020-07-03       Impact factor: 7.038

7.  Sclerotic-type chronic GVHD of the skin: clinical risk factors, laboratory markers, and burden of disease.

Authors:  Kathryn J Martires; Kristin Baird; Seth M Steinberg; Lana Grkovic; Galen O Joe; Kirsten M Williams; Sandra A Mitchell; Manuel Datiles; Fran T Hakim; Steven Z Pavletic; Edward W Cowen
Journal:  Blood       Date:  2011-07-26       Impact factor: 22.113

Review 8.  Immunotherapy and the Interventional Oncologist: Challenges and Opportunities-A Society of Interventional Oncology White Paper.

Authors:  Joseph P Erinjeri; Gabriel C Fine; Gosse J Adema; Muneeb Ahmed; Julius Chapiro; Martijn den Brok; Rafael Duran; Stephen J Hunt; D Thor Johnson; Jens Ricke; Daniel Y Sze; Beau Bosko Toskich; Bradford J Wood; David Woodrum; S Nahum Goldberg
Journal:  Radiology       Date:  2019-04-23       Impact factor: 11.105

9.  Effects of tumor irradiation on host T-regulatory cells and systemic immunity in the context of adoptive T-cell therapy in mice.

Authors:  Shuang Wei; Martin U Egenti; Seagal Teitz-Tennenbaum; Weiping Zou; Alfred E Chang
Journal:  J Immunother       Date:  2013-02       Impact factor: 4.456

10.  The effect of ionizing radiation on the homeostasis and functional integrity of murine splenic regulatory T cells.

Authors:  Andrea Balogh; Eszter Persa; Enikő Noémi Bogdándi; Anett Benedek; Hargita Hegyesi; Géza Sáfrány; Katalin Lumniczky
Journal:  Inflamm Res       Date:  2012-10-19       Impact factor: 4.575

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.